Results
eNauka >
Rezultati >
Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial
| Naziv: | Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial | Autori: | von, Minckwitz Gunter; Colleoni, Marco A; Kolberg, Hans-Christian; Morales, Serafin; Santi, Patricia Xavier; Tomasevic, Zorica I   ; Zhang, Nan; Hanes, Vladimir |
Godina: | 2018 | Publikacija: | LANCET ONCOLOGY | ISSN: | 1470-2045 Lancet Oncology Pretraži identifikator |
Izdavač: | Elsevier Ltd. | Tip rezultata: | Naučni članak | Kolacija: | vol. 19 br. 7 str. 987-998 | DOI: | 10.1016/S1470-2045(18)30241-9 | WoS-ID: | 000437342400057 | Scopus-ID: | 2-s2.0-85048539259 | URI: | https://enauka.gov.rs/handle/123456789/818305 | URL: | https://pubmed.ncbi.nlm.nih.gov/29880292/ https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30241-9/fulltext |
Projekat: | Amgen | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.